The level of insider selling is modest relative to market cap and appears tied to option exercises and personal liquidity planning. Monitor next earnings report for any guidance changes, but no immediate red flags.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 17 $59.81entry
- T+1 · 7mo ago +3.46%α +3.65% · $61.88
- T+5 · 7mo ago +1.89%α +1.33% · $60.94
- T+20 · 6mo ago −11.47%α −16.84% · $52.95
- T+60 · 4mo ago +54.71%α +48.56% · $92.53
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a combined $345K in shares over the past week, with the majority of the activity coming from the CFO's $240K open-market sale. The CEO also exercised options and sold a portion of the underlying shares, indicating planned disposition rather than broad insider concern.
Key Financial Metrics
Key Facts
- CEO Emily Leproust sold 1,610 shares for $104,666 on 2026-04-21 as part of an option exercise and sale transaction.
- CFO Adam Laponis sold 4,000 shares for $240,000 on 2026-04-17 in an open-market transaction.
- Total open-market sales in the cluster amount to $344,666, representing approximately 0.009% of the company's $3.9B market cap.
- CEO also exercised derivative securities totaling 11,281 shares, with $85,298 in aggregate exercise cost, but no additional open-market sales beyond the 1,610 shares.
Financial Impact
$345K in net insider selling over 7 days
Risk Factors
- Concentrated selling by top executives could signal reduced confidence if it continues in future filings.
- Future option exercises may lead to additional share sales, increasing near-term supply.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TWST-1776974751453 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers